Type I CD20 antibodies take over the B-cell receptor for complement-dependent cytotoxicity (CDC) of malignant B cellsFrank J Beurskens,Janine Schuurman,Paul Parren,Marleen Voorhorst,Jan G J Van De Winkel,Patrick J Engelberts,Joost M Bakker,Tom Vink,Wendy J M Mackus,Tom Van MeertenImmunobiology(2012)引用 0|浏览30暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要